Biomarkers · Vitamins & Endocrine
Dehydroepiandrosterone Sulfate (DHEA-S)
Higher values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.51top vs bottom quarter (95% CI 1.25–1.82) · EPIC-Heidelberg, n=7,370 men (mean age 55.0) and women (mean age 52.4), median follow-up 17.7 years
Where people sit
Population percentiles (ug/dL) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 20.1 | 52.4 | 85.3 | 132 | 241 | 353 | MIDUS 3 Biomarker Proj… |
| All | 40-59 | 20.1 | 52.4 | 85.3 | 132 | 241 | 353 | MIDUS 3 Biomarker Proj… |
| All | 60+ | 13.5 | 32.7 | 57.3 | 94.8 | 164 | 366 | MIDUS 3 Biomarker Proj… |
| All | all | 15.0 | 40.0 | 70.0 | 112 | 209 | 747 | MIDUS 3 Biomarker Proj… |
| Men | all | 21.0 | 48.0 | 84.0 | 122 | 255 | 330 | MIDUS 3 Biomarker Proj… |
| Women | all | 14.0 | 33.0 | 63.0 | 101 | 187 | 417 | MIDUS 3 Biomarker Proj… |
Sources
- Hazard curve: Synthesized from mortality_association (HR=1.51 quartile_extreme); per-SD log(HR)=0.322. Reported as quartile_extreme HR=1.51 for all-cause mortality. Original study used quintiles (not quartiles); comparison field approximated as quartile
- Association between dehydroepiandrosterone sulfate and mortality in middle-aged and older men and women-A J-shaped relationship. Journal of Clinical Endocrinology & Metabolism. 2023;108(6):e313-e323 (EPIC-Heidelberg cohort).
Map Dehydroepiandrosterone Sulfate (DHEA-S) against another biomarker.